Home

Stipendium Erleuchten Gründen eliquis vs xarelto gi bleeding Kapillaren Unfair Folter

Non-major bleeding with apixaban versus warfarin in patients with atrial  fibrillation | Heart
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation | Heart

Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC

Bleeding During Treatment With Aspirin Versus Apixaban in Patients With  Atrial Fibrillation Unsuitable for Warfarin | Stroke
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke

No INRs! RNs Role Caring for Patients on Oral Anticoagulant Therapy - ppt  download
No INRs! RNs Role Caring for Patients on Oral Anticoagulant Therapy - ppt download

Systematic review with meta‐analysis: the risk of major gastrointestinal  bleeding with non‐vitamin K antagonist oral anticoagulants - Caldeira -  2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Systematic review with meta‐analysis: the risk of major gastrointestinal bleeding with non‐vitamin K antagonist oral anticoagulants - Caldeira - 2015 - Alimentary Pharmacology & Therapeutics - Wiley Online Library

Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in  Asian Patients with Atrial Fibrillation | Scientific Reports
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports

What gastroenterologists should know about direct oral anticoagulants -  Digestive and Liver Disease
What gastroenterologists should know about direct oral anticoagulants - Digestive and Liver Disease

Through Thick and Thin: approaches to anticoagulant Reversal - ppt video  online download
Through Thick and Thin: approaches to anticoagulant Reversal - ppt video online download

GI bleeding on anticoagulants
GI bleeding on anticoagulants

Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC

Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral  Anticoagulants in Atrial Fibrillation: A Systematic Review and  Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology
Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology

Figure 32, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban,  or edoxaban (treatment) versus warfarin (control) (observational) - Stroke  Prevention in Patients With Atrial Fibrillation: A Systematic Review Update  - NCBI Bookshelf
Figure 32, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus warfarin (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf

Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral  Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect

What gastroenterologists should know about direct oral anticoagulants -  Digestive and Liver Disease
What gastroenterologists should know about direct oral anticoagulants - Digestive and Liver Disease

Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian  patients with non-valvular atrial fibrillation: An updated meta-analysis
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban,  and warfarin: population based cohort study | The BMJ
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study | The BMJ

Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in  Asian Patients with Atrial Fibrillation | Scientific Reports
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports

ESC 2015 Meeting Report
ESC 2015 Meeting Report

New predictive model for acute gastrointestinal bleeding in patients taking  oral anticoagulants: A cohort study - Shimomura - 2018 - Journal of Gastroenterology  and Hepatology - Wiley Online Library
New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study - Shimomura - 2018 - Journal of Gastroenterology and Hepatology - Wiley Online Library

Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... |  Download Scientific Diagram
Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... | Download Scientific Diagram

Restarting Warfarin vs Direct Oral Anticoagulants After Major  Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A  Cohort Study - Clinical Gastroenterology and Hepatology
Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study - Clinical Gastroenterology and Hepatology

Anticoagulation in the Post-Warfarin Era: Where Are We Today?
Anticoagulation in the Post-Warfarin Era: Where Are We Today?

Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban,  or edoxaban (treatment) versus dabigatran (control) (observational) -  Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review  Update - NCBI Bookshelf
Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus dabigatran (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf